{"id":"NCT03070119","sponsor":"Biogen","briefTitle":"Long-Term Evaluation of BIIB067 (Tofersen)","officialTitle":"An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB067 Administered to Previously Treated Adults With Amyotrophic Lateral Sclerosis Caused by Superoxide Dismutase 1 Mutation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-08","primaryCompletion":"2024-08-12","completion":"2024-08-12","firstPosted":"2017-03-03","resultsPosted":"2025-08-29","lastUpdate":"2025-08-29"},"enrollment":139,"design":{"allocation":"NON_RANDOMIZED","model":"SEQUENTIAL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation"],"interventions":[{"type":"DRUG","name":"Tofersen","otherNames":["BIIB067","QALSODY"]}],"arms":[{"label":"BIIB067","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB067 (tofersen) in participants with amyotrophic lateral sclerosis (ALS) and confirmed superoxide dismutase 1 (SOD1) mutation. The secondary objectives are to evaluate the pharmacokinetic (PK), pharmacodynamic (PD), biomarker effects, and efficacy of BIIB067 administered to participants with ALS and a confirmed SOD1 mutation.","primaryOutcome":{"measure":"Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Treatment Emergent Serious AEs (TESAEs)","timeFrame":"From first dose of the study drug in the current study up to end of follow-up period (up to Week 364)","effectByArm":[{"arm":"233AS101: Part C (Prior Placebo)","deltaMin":31,"sd":null},{"arm":"233AS101: Part C (Prior BIIB067 100 mg)","deltaMin":63,"sd":null},{"arm":"233AS101: Part A and B (All Doses)","deltaMin":43,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":30,"countries":["United States","Belgium","Canada","Denmark","France","Germany","Italy","Japan","United Kingdom"]},"refs":{"pmids":["36129998"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":32},"commonTop":["Headache","Procedural pain","Fall","Back pain","Arthralgia"]}}